Earnings News - Candlesense

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovat...

What is the potential impact of this earnings release on the stock's technical indicators and trading volume? How might the sentiment score of 10 influence market perception and short‑term price movement? Did the business update mention any changes in the capital structure, such as share issuances or debt financing, that could dilute existing shareholders?

Symbol: CYCC

28 days ago

Read more globenewswire

The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance

CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United Sta...

How might the reaffirmed full‑year guidance influence analyst sentiment and future earnings forecasts for TOI? Are there any risks or uncertainties highlighted in the release that could affect the company's guidance or stock performance? Did the company provide any updates on strategic initiatives, such as network expansion or new service lines, that could influence long‑term growth?

Symbol: TOI

28 days ago

Read more globenewswire

Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update

SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (A...

What macro‑economic or sector‑specific factors (e.g., biotech funding environment, FDA policy shifts) could amplify or mitigate the impact of this earnings release on the stock? How might the sentiment rating of 10 and the positive tone of the release translate into analyst upgrades or target price revisions? Is there any guidance on potential dilutive events (stock offerings, convertible debt) that could impact shareholder equity?

Symbol: ALLO

28 days ago

Read more globenewswire

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powe...

Is there any insider buying or selling activity around the earnings announcement? Did management comment on macroeconomic factors, such as hospital budgeting or capital‑equipment spending trends, that could affect demand? What are the potential short‑term catalysts (e.g., earnings release, conference presentations) that could move the stock?

Symbol: HYPR

28 days ago

Read more globenewswire

STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

HORSHAM, Penn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...

What is the implied impact of the reported results on the company’s long‑term growth outlook and market share in dermatology? How does STRATA's gross margin and operating expense trends compare to its historical trends and industry averages? Are there any changes to the management team or board that could influence execution of the strategy?

Symbol: SSKN

28 days ago

Read more globenewswire

AirJoule Technologies Announces Second Quarter 2025 Results

RONAN, Mont., Aug. 13, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading technology platform that unleashes the power...

What are the potential macroeconomic factors (e.g., water scarcity trends, climate policies) that could influence AirJoule's long‑term market opportunities? How did the stock price react immediately after the earnings release, and what are the key technical levels to watch for further movement? What is the impact of the reported sentiment score of 10 on investor sentiment and potential short-term trading strategies?

Symbol: AIRJ

28 days ago

Read more globenewswire

SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026

BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology company, today announced its financial results ...

How might the revised guidance influence short‑term trading activity and price volatility of SURG stock? What macro‑economic or regulatory risks could affect the company's forward‑looking guidance? Will the company need additional equity or debt financing to meet its growth targets, and what dilution or leverage risks does that pose?

Symbol: SURG

28 days ago

Read more prnewswire

Inhibrx Reports Second Quarter 2025 Financial Results

SAN DIEGO, Aug. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the second quarter of 2025. Following the complet...

What is the analyst consensus and target price revision, if any, following this earnings release? Are there any risks or uncertainties disclosed in the filing that could affect future performance (e.g., litigation, regulatory delays)? What is the outlook for the remaining INBRX product candidates and their potential impact on revenue growth?

Symbol: INBX

28 days ago

Read more prnewswire

Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Second Quarter Ended July 13, 2025

ENGLEWOOD, Colo., Aug. 13, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of hig...

How does the current valuation (e.g., P/E, EV/EBITDA) compare to historical averages and sector peers? Are there any macroeconomic or consumer trends highlighted that could affect future performance? Did the company mention any operational initiatives or menu innovations that could drive future growth?

Symbol: RRGB

28 days ago

Read more prnewswire

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for ...

How might the recent earnings and guidance influence the stock price and trading volume in the near term? What is the outlook for capital expenditures and R&D spending in FY26, and how might that affect profitability? Are there any upcoming product launches, regulatory approvals, or pipeline developments that could impact future results?

Symbol: ARAY

28 days ago

Read more prnewswire